# Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteers

> **NCT01868438** · PHASE1 · COMPLETED · sponsor: **Medicines for Malaria Venture** · enrollment: 60 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Pyronaridine-artesunate granules
- **DRUG:** Pyronaridine-artesunate tablets

## Key facts

- **NCT ID:** NCT01868438
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-10
- **Final completion:** 2014-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01868438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01868438, "Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01868438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*